Farnum Rhonda 4
4 · Theravance Biopharma, Inc. · Filed May 22, 2026
Research Summary
AI-generated summary of this filing
Theravance Biopharma (TBPH) SVP Rhonda Farnum Withholds 5,678 Shares
What Happened Rhonda Farnum, Senior Vice President, Commercial & Medical Affairs at Theravance Biopharma (TBPH), had 5,678 shares withheld to satisfy tax obligations arising from the vesting of previously granted restricted stock units. The withholding was recorded on 2026-05-20 at a price of $16.55 per share, totaling approximately $93,971. This was a tax-withholding disposition (code F), not an open-market sale.
Key Details
- Transaction date and price: 2026-05-20 at $16.55 per share.
- Shares withheld / disposed: 5,678 shares, value ≈ $93,971.
- Shares owned after transaction: Not specified in the provided filing summary.
- Footnote: F1 — shares were withheld by the issuer to cover taxes from RSU vesting; no open market transaction occurred.
- Filing timeliness: No late-filing indication provided in the supplied data.
Context This was a routine tax-withholding event following RSU vesting (cashless share withholding) rather than a sale executed in the market, so it should not be interpreted as a directional buy/sell signal. Tax-withholdings are common when equity awards vest and do not necessarily reflect the insider’s view on the company’s prospects.
Insider Transaction Report
- Tax Payment
Ordinary Shares
[F1]2026-05-20$16.55/sh−5,678$93,971→ 245,771 total
Footnotes (1)
- [F1]Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.